Feinsod Matthew (CIK 1716950) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-03-18). Recent activity: Buy KLRS (4,030 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-18 | Kalaris Therapeutics, Inc. (KLRS) | Chief Medical Officer | Buy | 4,030 | $0 |
Source: SEC Form 4 filings · as of 2025-03-18